What is NeuroServo?
NeuroServo operates at the intersection of medical technology and neurology, providing advanced electroencephalogram (EEG) solutions tailored for hospital environments. The company's core mission centers on the mitigation of permanent brain damage through the rapid identification of neurological abnormalities. By streamlining seizure confirmation and sedation monitoring, NeuroServo provides medical staff with the actionable data required to improve patient outcomes in emergency settings. Their market position is defined by a commitment to continuous monitoring, a segment of the healthcare industry that is increasingly prioritizing data-driven, real-time diagnostic tools to manage patients with altered states of consciousness.
How much funding has NeuroServo raised?
NeuroServo has raised a total of $1.7M across 1 funding round:
Angel/Seed
$1.7M
Angel/Seed (2023): $1.7M with participation from Centre for Aging and Brain Health Innovation, Desjardins Capital, and Investissement Quebec
Key Investors in NeuroServo
Centre for Aging and Brain Health Innovation
CABHI is a solution accelerator focused on driving innovation in the aging and brain health sector by collaborating with healthcare, science, and government partners.
Desjardins Capital
Desjardins Capital manages investment funds dedicated to supporting the growth and development of small and medium-sized enterprises.
Investissement Quebec
A government-backed entity providing financial solutions, including loans and equity investments, to foster economic development and job creation.
What's next for NeuroServo?
With the support of its latest financial backing, NeuroServo is poised to scale its operations and refine its diagnostic algorithms. The company's strategic roadmap likely involves expanding its footprint within critical care departments, where the demand for reliable, continuous EEG monitoring remains high. By leveraging the expertise of its institutional partners, NeuroServo is well-positioned to navigate the regulatory landscape and enhance its commercialization efforts. Future growth will likely be driven by the adoption of its technology in major healthcare networks, further cementing its role as a leader in brain health innovation and clinical diagnostic efficiency.
See full NeuroServo company page
